Medical scientists have come up with the latest clinical trial results showing evidence where high amounts of immunosuppressive treatment followed by own blood-forming stem cells transplants that can induce continual remission of relapsed –submission of multiple sclerosis, an autoimmune illness where the immune system attacks the (CNS) Central Nervous System. Five years into the clinical trial therapies, 69 percent of the test patients survived without a series of disabilities, relapses of MS or new brain lesions upon receiving the (HDIT/HCT) high-dose immune-suppressive therapy/hematopoietic cell transplant.
The patients were not under any medication after getting HDIT/HCT. Additional research indicates that the available MS drug lowers the success rates. The HALT-MS trial was supported and managed by NIAID, (National Institute of Allergy, and Infectious Diseases) in conjunction with NIH, and (ITN) Immune Tolerance Network (funded by NIAID). The overall results imply that a single treatment with HDIT/HCT may prove to be more valuable than any long-term therapy. MS symptoms are extremely broad and may consist of speech complications, fatigue, and constant pain.
Relapsing-remitting MS, the universal form of MS is distinguished by episodes of mild symptoms combined with symptom outbursts or relapses. The disease can deteriorate with time and change to a progressive form. Five years after the HDIT/HCT trial, some patients showed recovery improvements, such as mobility or new physical abilities. While further assessment of HDIT/HCT is required, the five-year results imply the assurance of this cure to induce long-term, continuous remission of poor relapsing-remitting MS prognosis.
Dr Shiva Gopal Vasishta is a Medicare Psychiatry & Neurology physician based in Voorhees, New Jersey. Dr Shiva Gopal Vasishta graduated (MD) in 1979 from medical school and has practiced medicine for nearly 38 years with extensive experience specifically in Neurology. Dr Shiva Gopal Vasishta is a fully licensed practicing neurologist who actively partners with the Medicare government program.
He works on Medicare patients and does not bill his referred patients’ excess amounts over and above the insurance and Medicare-approved sum. He is a member of the Eastern Neuro-diagnostic Association Practice group. Dr Shiva Gopal Vasishta currently practices from 2301 Evesham Rd, Suite 209, Pavilion 800, Voorhees, NJ.